The clinical efficacy of oral levodopa methyl ester solution in reversing afternoon "off" periods in Parkinson's disease.

Steiger, M J; Stocchi, F; Carta, A; Ruggieri, S; Agnoli, A; Quinn, N P; Marsden, C D

Steiger, M J; Stocchi, F; Carta, A; Ruggieri, S; Agnoli, A; Quinn, N P; Marsden, C D.

Affiliation

Steiger MJ; Department of Clinical Neurology, Institute of Neurology, London, U.K.

Clin Neuropharmacol ; 14(3): 241-4, 1991 Jun.

Article in En | MEDLINE | ID: mdl-2070364

Subject(s)

Benserazide/administration & dosage; Levodopa/analogs & derivatives; Levodopa/administration & dosage; Parkinson Disease/drug therapy; Administration, Oral; Aged; Benserazide/therapeutic use; Drug Combinations; Humans; Levodopa/therapeutic use; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Benserazide / Levodopa Limits: Aged / Humans / Middle aged Language: En Journal: Clin Neuropharmacol Year: 1991 Document type: Article Affiliation country: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links